ReadmissionPREVENT-RNCT07890961
A Clinician-Patient Dual Behavior Change Framework to Leverage Informed Digital Nudges to Reduce Hospital Readmissions and Improve Patient Outcomes: A Trial for Scalable Strategy to Reduce Readmissions (PREVENT-R)
A study testing Digital nudge prompting in people with Readmission and Readmission Rates, run by Yale University at 1 site in United States.
Trial summary
The PREVENT-R trial will evaluate an intervention targeting both clinician and patient behavior. The clinician-focused piece consists of an electronic medical record-based digital nudge presented to emergency department clinicians caring for eligible older adults at high risk of readmission. Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Readmission, Readmission Rates, Readmission, Hospital
- What is being tested?
- Digital nudge prompting
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 800 participants
- Where
- 1 siteUnited States
- Study dates
- Nov 2026to Nov 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- Patient Participants:
- Hospitalization within the previous 30 days.
- Identified as being at high risk for readmission by the EMR-embedded algorithm.
- Reside in a geographic area identified as having high health-related social needs based on the Community Health Needs Assessment (CHNA).
- For consent-dependent patient research activities, able to provide informed consent.
- Clinician Participants:
Show all 9Show fewer
- ED clinicians who have experience with the PREVENT-R intervention and/or SNP referral process and are able to provide informed consent for participation in the qualitative interview.
- Service Navigator Participants:
- Individuals involved in delivering SNP services to patients enrolled in or referred through PREVENT-R and who are able to provide informed consent for participation in the qualitative interview.
Who cannot join
- Patient Participants:
- Require immediate hospital admission.
- Receiving hospice, skilled nursing facility, or palliative care.
- Unable to participate in study procedures in English or Spanish.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Yale New Haven Hospital System
New Haven, Connecticut, 06520
About this study
Official title: A Clinician-Patient Dual Behavior Change Framework to Leverage Informed Digital Nudges to Reduce Hospital Readmissions and Improve Patient Outcomes: A Randomized Trial for Scalable Strategy to Reduce Readmissions (PREVENT-R)
The PREVENT-R trial will evaluate an intervention targeting both clinician and patient behavior. The clinician-focused piece consists of an electronic medical record-based digital nudge presented to emergency department clinicians caring for eligible older adults at high risk of readmission. The nudge is intended to prompt clinicians to consider referral to the Service Navigator Program from the Agency on Aging of South Central Connecticut for patients with needs that may be addressed through community-based services and supports. The study will evaluate whether these mechanisms (clinician referral and patient program acceptance behavior) are associated with subsequent Emergency Department (ED) revisits and 30-day hospital re-admissions.
- Being tested
- Digital nudge prompting
- Keywords
- Digital Health
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Digital nudge promptingBehavioural
The EMR will generate a digital nudge prompting the treating ED clinician to consider referral of the patient to the SNP.
| Study group | Role | What they receive |
|---|---|---|
| EMR-based digital nudge | Experimental | The EMR will generate a digital nudge prompting the ED clinician to consider referral of the eligible patient to the SNP. Patients referred to the SNP will have the opportunity to engage with an SN and receive individualized navigation and support based on their identified needs. Receives: Behavioral: Digital nudge prompting |
| Control Arm | No intervention | No study-related EMR digital nudge will be generated. Clinicians will proceed with usual ED care and discharge practices, which may include referral to the SNP when clinically appropriate. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage of participants with hospital readmissions
Hospital readmission within 30 days of the index ED visit.
Measured: 30 days following the index ED
Secondary outcomes (5)
Percentage of participants referred to the SNP
Percentage of participants referred to the SNP to assess clinician referral behavior
Measured: up to 3 months
Percentage of participants that accept or decline SNP services
Percentage of participants that accept or decline SNP services among those referred to and successfully contacted by the SNPt o assess patient acceptance
Measured: up to 3 months
Post-SNP assessment
Patient-reported experience and outcomes will be assessed using the SNP survey administered at completion of SNP services. (This assessment is currently being refined.)
Measured: up to 3 months
Percentage of participants that interact with SNs
Percentage of intervention arm participants that interact with SNs
Measured: up to 3 months
Percentage of participants that utilize services
Percentage of intervention arm participants that utilized recommended services and supports.
Measured: up to 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Oct 2026
- Study startNov 2026 (estimated)
- Primary completionMay 2028 (estimated)
- Study completionNov 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ReadmissionStudies of the same condition, open and under way.
- More trials run by Yale UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Adults aged 65 years and older presenting to the YNHH ED at the York Street and Saint Raphael Campus locations who have had a hospitalization within the previous 30 days and are identified by an EMR-embedded algorithm as being at high risk for readmission.
- Masking
- None (open label)
- Enrolment
- 800 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Yale University
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Aging (NIA)
- Responsible party
- Sponsor
- Investigators
- Fuad Abujarad, PhD, MSc, Principal investigator, Yale University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07890961
- Sponsor's protocol ID
- 2000043602
- Other IDs
- 5P30AG024968-24
- Acronym
- PREVENT-R
- Status last verified
- Oct 2026
- First submitted
- 15 Oct 2026
- Last updated
- 29 Oct 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Clinician-Patient Dual Behavior Change Framework to Leverage Informed Digital Nudges to Reduce Hospital Readmissions and Improve Patient Outcomes: A Randomized Trial for Scalable Strategy to Reduce Readmissions (PREVENT-R)
- ClinicalTrials.gov ID
- NCT07890961
- Acronym / sponsor ID
- PREVENT-R / 2000043602
- Keywords
- Digital Health
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 800 participants (estimated)
- Lead sponsor
- Yale UniversityUniversity, hospital or other
- Collaborators
- National Institute on Aging (NIA)
- Study start
- Nov 2026 (estimated)
- Primary completion
- May 2028 (estimated)
- Study completion
- Nov 2028 (estimated)
- First posted
- 23 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The PREVENT-R trial will evaluate an intervention targeting both clinician and patient behavior. The clinician-focused piece consists of an electronic medical record-based digital nudge presented to emergency department clinicians caring for eligible older adults at high risk of readmission. The nudge is intended to prompt clinicians to consider referral to the Service Navigator Program from the Agency on Aging of South Central Connecticut for patients with needs that may be addressed through community-based services and supports. The study will evaluate whether these mechanisms (clinician referral and patient program acceptance behavior) are associated with subsequent Emergency Department (ED) revisits and 30-day hospital re-admissions.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Adults aged 65 years and older presenting to the YNHH ED at the York Street and Saint Raphael Campus locations who have had a hospitalization within the previous 30 days and are identified by an EMR-embedded algorithm as being at high risk for readmission.
| Arm | Type | Receives |
|---|---|---|
| EMR-based digital nudge | Experimental | Behavioral: Digital nudge promptingThe EMR will generate a digital nudge prompting the ED clinician to consider referral of the eligible patient to the SNP. Patients referred to the SNP will have the opportunity to engage with an SN and receive individualized navigation and support based on their identified needs. |
| Control Arm | No intervention | –No study-related EMR digital nudge will be generated. Clinicians will proceed with usual ED care and discharge practices, which may include referral to the SNP when clinically appropriate. |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (9 listed)
- Hospitalization within the previous 30 days.
- Identified as being at high risk for readmission by the EMR-embedded algorithm.
- Reside in a geographic area identified as having high health-related social needs based on the Community Health Needs Assessment (CHNA).
- For consent-dependent patient research activities, able to provide informed consent.
- ED clinicians who have experience with the PREVENT-R intervention and/or SNP referral process and are able to provide informed consent for participation in the qualitative interview.
Key exclusion criteria (4 listed)
- Require immediate hospital admission.
- Receiving hospice, skilled nursing facility, or palliative care.
- Unable to participate in study procedures in English or Spanish.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Digital nudge promptingThe EMR will generate a digital nudge prompting the treating ED clinician to consider referral of the patient to the SNP. | Behavioural | EMR-based digital nudge |
Primary outcome
Percentage of participants with hospital readmissions
Time frame: 30 days following the index ED
Hospital readmission within 30 days of the index ED visit.
5 secondary outcomes
Percentage of participants referred to the SNP
Time frame: up to 3 months
Percentage of participants that accept or decline SNP services
Time frame: up to 3 months
Post-SNP assessment
Time frame: up to 3 months
Percentage of participants that interact with SNs
Time frame: up to 3 months
Percentage of participants that utilize services
Time frame: up to 3 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Oct 2026.
- Individual participant dataSharing planned: No
Related trials for Readmission
Recruiting
Pericardiotomy in Cardiac Surgery
Atrial Fibrillation, Atrial Flutter
Recruiting
COordiNated CommuNication, Education, and Care Transitions After Acute Kidney Injury (CONNECT-AKI)
Acute Kidney Injury, Acute Kidney Injury (AKI)
Active, not recruitingObservational study
Psychoactive Drug Use and Acute Care Use After Trauma and Out-of-Hospital Cardiac Arrest
Wounds and Injuries, Out-of-Hospital Cardiac Arrest
Recruiting
Conducting Wound, Ostomy, and Continence (WOC) Nurse Telephone Follow-up for Post-discharge Ostomy Patients to Reduce Hospital Readmission
Ostomy
Not yet recruiting
Evaluation of a French Hospital Discharge Therapeutic Education Program by Nurses for Heart Failure Patient (EduSor)
Heart Failure
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Fuad Abujarad, PhD, MSc principal investigator
Yale University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Digital nudge prompting in people with Readmission and Readmission Rates, run by Yale University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 29 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Fuad Abujarad, PhD, MSc (203-737-5088, fuad.abujarad@yale.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage of participants with hospital readmissions (time frame: 30 days following the index ED). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2026.